A Double-Blind, Placebo-Controlled, Randomised Dose Ranging Trial to Investigate the Efficacy of Two Different Dosing Regimens of Avotermin (Juvista) in the Improvement of Scar Appearance When Applied to Approximated Wound Margins in Healthy Volunteers.
Latest Information Update: 20 May 2014
At a glance
- Drugs Avotermin (Primary)
- Indications Scars
- Focus Therapeutic Use
- Sponsors Renovo
Most Recent Events
- 20 May 2014 New trial record